The Central Melanocortin System and Regulation of Energy Balance
The Central Melanocortin System and Regulation of Energy Balance
批准号:
8231464
负责人:
Sharon L. Wardlaw
金额:
$33.53万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-01-01 至 2013-12-31
关键词:
ART proteinAffectBiologicalBiological AssayBody WeightBrainC-terminalDiabetes MellitusDietEatingEnergy MetabolismEnzymesFatty LiverFatty acid glycerol estersGenetic ModelsHealthHepaticHormonalHumanHypothalamic structureIn VitroInjection of therapeutic agentMusMutationN-terminalNamesNeuronsNutrientObesityPeptidesPeripheralPlayPrevalencePreventionPrincipal InvestigatorPro-OpiomelanocortinProcessProprotein Convertase 1Protocols documentationRegulationResearchRodent ModelRoleSignal TransductionSystemTransgenic Micedesignenergy balancefeedingglucose metabolismimprovedin vivomelanocortin receptornovelnutrient metabolismoverexpressionoxidationprogramsresponsesmall molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term objective of this proposal is to understand how the brain senses levels of peripheral energy stores and integrates these signals to maintain energy balance. Studies will focus on the central melanocortin system in rodent models and on the mechanisms by which it can sense and integrate a variety of nutrient, hormonal and neuronal signals to regulate food intake, energy expenditure and nutrient metabolism. This system consists of proopiomelanocortin (POMC) and the POMC-derived MSH peptides together with agouti related protein (AGRP) which is a potent antagonist of the MSH peptides at specific melanocortin receptors (MC3/4-R). a-MSH inhibits feeding and stimulates energy expenditure while AGRP exerts opposite effects. Aim 1 will use recently generated transgenic mice that overexpress a-MSH and g- MSH (Tg-MSH) to study the role of the melanocortin system in modulating responses to energy excess on a high fat diet and to characterize underlying mechanisms with a focus on energy expenditure, fuel oxidation, sympathetic activity and hepatic steatosis. Tg-MSH mice demonstrate reduced body weight, adiposity and hepatic fat accumulation (without changes in food intake) and improved glucose metabolism, particularly in the setting of diet-induced obesity. The role of AGRP will be similarly studied in Aim 2 using a genetic model of Agrp deletion and a novel, potent, small molecule AGRP antagonist. Aims 3 & 4 will focus on the regulation of POMC and AGRP peptide processing in the hypothalamus in vivo and in vitro with respect to energy balance. This is an important consideration because POMC is processed to a number of peptides with different and even opposing biological activities. The ability of these peptide products to interact and regulate energy balance will be studied in parallel using icv injection protocols. AGRP is also processed by PC1 to a biologically active C-terminal fragment but little is known about the regulation of processing or about the N-terminal peptides that are produced that may also affect energy balance. AGRP processing will be characterized using novel assays and the effects of these processed peptides on energy balance will then be studied. This proposal is highly relevant to human energy balance as mutations in POMC, POMC processing enzymes and in the MC4-R have all been associated with human obesity and there are many parallels with rodent models of melanocortin deficiency.
PUBLIC HEALTH RELEVANCE: The increasing prevalence of obesity and diabetes makes it imperative to understand the mechanisms by which the brain regulates energy balance in order to design more effective prevention and treatment options. This proposal will use rodent models to study the brain melanocortin system which plays a key role in regulating energy balance. This system consists of proopiomelanocortin (POMC) and the POMC-derived MSH peptides together with agouti related protein (AGRP) which is a potent antagonist of the MSH peptides at specific melanocortin receptors (MC3/4-R). ?-MSH inhibits feeding and stimulates energy expenditure while AGRP exerts opposite effects. This proposal is highly relevant to human energy balance as mutations in POMC, POMC processing enzymes and in the MC4-R have all been associated with human obesity and there are many parallels with rodent models of melanocortin deficiency.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Effects of Naltrexone on Energy Balance and Hypothalamic Melanocortin Peptides in Male Mice Fed a High-Fat Diet.
纳曲酮对高脂饮食雄性小鼠能量平衡和下丘脑黑皮质素肽的影响。
DOI:
10.1210/js.2018-00379
发表时间:
2019
期刊:
Journal of the Endocrine Society
影响因子:
4.1
作者:
[Panigrahi,SunilK, Meece,Kana, Wardlaw,SharonL]
通讯作者:
Wardlaw,SharonL
DOI:
10.1016/j.peptides.2012.07.006
发表时间:
2012-09
期刊:
Peptides
影响因子:
3
作者:
[Dutia R, Kim AJ, Mosharov E, Savontaus E, Chua SC Jr, Wardlaw SL]
通讯作者:
Wardlaw SL
CSF Neuropeptide, Hormonal and Metabolomic Analysis in Human Energy Balance
-
批准号:8703681
-
项目类别:
-
资助金额:$34.8万
-
财政年份:2011
-
负责人:Sharon L. Wardlaw
-
依托单位:
CSF Neuropeptide, Hormonal and Metabolomic Analysis in Human Energy Balance
-
批准号:8335397
-
项目类别:
-
资助金额:$34.8万
-
财政年份:2011
-
负责人:Sharon L. Wardlaw
-
依托单位:
CSF Neuropeptide, Hormonal and Metabolomic Analysis in Human Energy Balance
-
批准号:8505010
-
项目类别:
-
资助金额:$33.58万
-
财政年份:2011
-
负责人:Sharon L. Wardlaw
-
依托单位:
CSF Neuropeptide, Hormonal and Metabolomic Analysis in Human Energy Balance
-
批准号:8218328
-
项目类别:
-
资助金额:$34.8万
-
财政年份:2011
-
负责人:Sharon L. Wardlaw
-
依托单位:
CSF Neuropeptide, Hormonal and Metabolomic Analysis in Human Energy Balance
-
批准号:8881157
-
项目类别:
-
资助金额:$34.8万
-
财政年份:2011
-
负责人:Sharon L. Wardlaw
-
依托单位:
CSF Neuropeptide, Hormonal and Metabolomic Analysis in Human Energy
-
批准号:9514976
-
项目类别:
-
资助金额:$54.47万
-
财政年份:2011
-
负责人:Sharon L. Wardlaw
-
依托单位:
The Central Melanocortin System and Regulation of Energy Balance
-
批准号:8034539
-
项目类别:
-
资助金额:$9.39万
-
财政年份:2010
-
负责人:Sharon L. Wardlaw
-
依托单位:
The Central Melanocortin System and Regulation of Energy Balance
-
批准号:8033115
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2008
-
负责人:Sharon L. Wardlaw
-
依托单位:
The Central Melanocortin System and Regulation of Energy Balance
-
批准号:7750580
-
项目类别:
-
资助金额:$33.87万
-
财政年份:2008
-
负责人:Sharon L. Wardlaw
-
依托单位:
The Central Melanocortin System and Regulation of Energy Balance
-
批准号:7540456
-
项目类别:
-
资助金额:$34.21万
-
财政年份:2008
-
负责人:Sharon L. Wardlaw
-
依托单位:
Hypothalamic Regulation of Energy Homeostasis
-
批准号:6635243
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:Sharon L. Wardlaw
-
依托单位:
Hypothalamic Regulation of Energy Homeostasis
-
批准号:6369261
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:Sharon L. Wardlaw
-
依托单位:
Hypothalamic Regulation of Energy Homeostasis
-
批准号:6517729
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:Sharon L. Wardlaw
-
依托单位:
Hypothalamic Regulation of Energy Homeostasis
-
批准号:6769401
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:Sharon L. Wardlaw
-
依托单位:
Cytokines and Hypothalamic-Pituitary-Immune Interactions
-
批准号:6577628
-
项目类别:
-
资助金额:$40.88万
-
财政年份:1998
-
负责人:Sharon L. Wardlaw
-
依托单位:
Cytokines and Hypothalamic-Pituitary-Immune Interactions
-
批准号:6686801
-
项目类别:
-
资助金额:$36.79万
-
财政年份:1998
-
负责人:Sharon L. Wardlaw
-
依托单位:
Cytokines and Hypothalamic-Pituitary-Immune Interactions
-
批准号:6832797
-
项目类别:
-
资助金额:$36.79万
-
财政年份:1998
-
负责人:Sharon L. Wardlaw
-
依托单位:
Cytokines and Hypothalamic-Pituitary-Immune Interactions
-
批准号:7156927
-
项目类别:
-
资助金额:$34.88万
-
财政年份:1998
-
负责人:Sharon L. Wardlaw
-
依托单位:
CYTOKINES AND HYPOTHALAMIC-PITUITARY-IMMUNE INTERACTIONS
-
批准号:6165170
-
项目类别:
-
资助金额:$26.62万
-
财政年份:1998
-
负责人:Sharon L. Wardlaw
-
依托单位:
CYTOKINES AND HYPOTHALAMIC-PITUITARY-IMMUNE INTERACTIONS
-
批准号:2883394
-
项目类别:
-
资助金额:$25.84万
-
财政年份:1998
-
负责人:Sharon L. Wardlaw
-
依托单位:
海外基金